Gut microbiota metabolism of azathioprine: a new hallmark for personalized drug-targeted therapy of chronic in fl ammatory bowel disease

HIGHLIGHTS

• who: Personalized Drug-Targeted Therapy and collaborators from the Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Queen Elizabeth II Medical Centre, Nedlands, WA, Australia have published the research: Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic In fl ammatory Bowel Disease, in the Journal: Gut Microbiota Metabolism of Azathioprine
• what: As this field is lacking the overall systematic understanding of direct microbial enzymatic biotransformation of azathioprine, the authors intended, by a selection of gut microbiota-derived enzymes, to direct . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.